https://www.hgvireland.com/alexion-and-dhl-express-announce-landmark-partnership/
Alexion and DHL Express announce landmark partnership - HGV Ireland
Feb 25, 2025 - Alexion, AstraZeneca Rare Disease, and DHL Express have announced a landmark partnership in a bid to reduce greenhouse gas emissions (GHG) from the air freight...
dhl expressalexionannouncelandmarkpartnership
https://www.cmlviz.com/stocks/ALXN/news/2015/06/30/ALXN
Why Alexion Stock Could Rip - CMLViz.com
alexionstockcouldrip
https://www.lobbyregister.bundestag.de/inhalte-der-interessenvertretung/regelungsvorhabensuche/RV0017192
Regelungsvorhaben "Beibehaltung der Orphan-Drug Regulierung im AMNOG" von "Alexion Pharma Germany...
Beibehaltung der Orphan-Drug Regulierung im AMNOG
derorphandrugregulierungim
https://ipverse.greyb.com/unified-patent-court/cases/case-details/amgen-vs-alexion-pharmaceuticals--app-32868-2025
Amgen AB vs. Alexion Pharmaceuticals - APP_32868/2025 - IP Verse
The case APP_32868/2025 was filed by the plaintiff Amgen AB against the defendant Alexion Pharmaceuticals, Inc. on 14 Jul, 2025.
amgenabvsalexionpharmaceuticals
https://bulios.com/ticker/AXP.DE
Alexion Pharmaceuticals, Inc. (AXP.DE) Stock | AXP.DE Stock Price & Analysis - Bulios
Get the latest news and market analysis for Alexion Pharmaceuticals, Inc. (AXP.DE). Stay up-to-date on AXP.DE Stock price and share price with Bulios. Explore...
alexion pharmaceuticals incstock priceaxpdeanalysis
https://www.ahusallianceaction.org/some-insights-into-alexion-2018/
Some insights into Alexion 2018. - aHUS Alliance Action
Apr 29, 2019 - As it is obligated to do, on 14 May 2019 Alexion will be holding its shareholders meeting to report on how things went in 2018. Its financial performance for...
insightsalexionahusallianceaction
https://www.3blmedia.com/news/alexion-receives-boston-cares-2020-corporate-partner-year-award
Alexion Receives Boston Cares 2020 Corporate Partner of the
Alexion is honored to receive the 2020 Corporate Partner of the Year Award from volunteer agency Boston Cares as part of their annual Boston Cares Awards...
corporate partneralexionreceivesbostoncares
https://adisinsight.springer.com/patents/800022062
Betrixaban - Alexion AstraZeneca Rare Disease - AdisInsight
rare diseasealexionastrazeneca
https://contratos-publicos.comunidad.madrid/contrato-publico/suministro-eculizumab-distribuido-exclusividad-laboratoio-alexion-pharma-spain
Suministro de Eculizumab distribuido en exclusividad por el laboratoio ALEXION PHARMA SPAIN, en el...
Suministro de Eculizumab distribuido en exclusividad por el laboratoio ALEXION PHARMA SPAIN, en el Hospital Universitario Puerta de Hierro Majadahonda
suministrodeenporel
https://www.farmaciaospedaliera.it/tag/alexion/
Alexion Archivi - Farmacia Ospedaliera
farmacia ospedalieraalexionarchivi
https://hartfordbusiness.com/article/ct-green-building-council-honors-alexion-15-others/
CT Green Building Council honors Alexion, 15 others
May 14, 2025 - The Connecticut Green Building Council will honor New Haven drug maker Alexion Pharmaceuticals, Middletown office park Centerpoint Connecticut and 14 other...
green building councilcthonorsalexionothers
https://biohealthinnovation.org/astrazeneca-to-acquire-alexion-for-39-billion-in-blockbuster-deal/
AstraZeneca to acquire Alexion for $39 billion in blockbuster deal - BioHealth Innovation
May 22, 2025 - AstraZeneca on Saturday said it was acquiring Alexion Pharmaceuticals for $39 billion, marking a significant expansion into the treatment of rare diseases of...
astrazenecaacquirealexionbillionblockbuster
https://www.fool.com/investing/2021/07/17/with-the-alexion-acquisition-set-to-close-this-qua/
With the Alexion Acquisition Set to Close This Quarter, Is AstraZeneca a Buy? | The Motley Fool
Jul 17, 2021 - With UK approval, the $39 billion deal for rare disorders biotech company Alexion Pharmaceuticals is set to close on July 21.
set toclose thismotley foolalexionacquisition
https://www.aitia.com/tag/alexion/
Alexion Archives - Aitia
alexionarchives
https://www.chemdiv.com/company/media/pharma-news/2019/alexion-acquiring-achillion-to-expand-reach-into-rare-immune-related-disease/
Alexion acquiring Achillion to expand reach into rare, immune-related disease -...
Alexion acquiring Achillion to expand reach into rare, immune-related disease
expand reachalexionacquiringrareimmune
https://alexion.com/innovation
Innovation | Alexion Global Site
global siteinnovationalexion
https://www.distilnfo.com/lifesciences/2020/05/12/alexion-set-to-acquire-portola-pharmaceuticals-in-1-41-billion-deal/
Alexion Set to Acquire Portola Pharmaceuticals in $1.41 Billion Deal - DistilINFO LifeSciences
May 12, 2020 - Shares of Portola Pharmaceuticals more than doubled in premarket trading on news that Boston-based Alexion Pharmaceuticals is acquiring the company... Continue...
set toalexionacquireportolapharmaceuticals
https://pitchgrade.com/companies/alexion-pharmaceuticals
Alexion Pharmaceuticals: Business Model, SWOT Analysis, and Competitors 2026 - PitchGrade
In-depth 2026 analysis of Alexion Pharmaceuticals: business model, SWOT analysis, and competitive landscape. Understand how Alexion Pharmaceuticals operates...
business modelswot analysisalexionpharmaceuticalscompetitors
https://biopharma.news/astrazeneca-alexion-rescue-of-both-companies-1401/
AstraZeneca + Alexion = Rescue of Both Companies | BioPharma.News
Sep 8, 2022 - Alexion Pharmaceuticals, which owns Soliris, one of the most expensive drugs on Earth, has agreed to sell AstraZeneca for $39 billion.
biopharma newsastrazenecaalexionrescuecompanies
https://markets.businessinsider.com/stocks/alxn-stock
Alexion Pharmaceuticals Stock Price | ALXN Stock Quote, News, and History | Markets Insider
The latest Alexion Pharmaceuticals stock prices, stock quotes, news, and ALXN history to help you invest and trade smarter.
stock pricemarkets insideralexionpharmaceuticalsquote
https://www.mlex.com/mlex/articles/2326477/alexion-pharmaceuticals-accused-of-gaming-us-patent-system-to-block-soliris-competition
Alexion Pharmaceuticals accused of gaming US patent system to block Soliris competition | MLex |...
MLex Summary: EmblemHealth filed a US complaint today accusing Alexion Pharmaceuticals of unlawfully delaying the introduction of biosimilar competition for...
alexionpharmaceuticalsaccusedgamingpatent
https://www.diwou.com/tag/alexion-pharmaceuticals/
Alexion Pharmaceuticals Archives - American Biotech News
biotech newsalexionpharmaceuticalsarchivesamerican
https://www.indianpharmapost.com/rd/alexion-to-showcase-broad-neurology-pipeline-at-aan-2026-with-20-presentations-19700
Alexion to showcase broad neurology pipeline at AAN 2026 with 20 presentations
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world...
alexionshowcasebroadneurologypipeline
https://www.insidebidensbasement.org/organizations/alexion-pharmaceuticals
Organization - Alexion Pharmaceuticals - Biden's Basement
Track Biden's Appointees and Staff Across the Government
organizationalexionpharmaceuticalsbidenbasement